ES2136662T3 - Formas de presentacion farmaceuticas y de otro tipo. - Google Patents

Formas de presentacion farmaceuticas y de otro tipo.

Info

Publication number
ES2136662T3
ES2136662T3 ES93911039T ES93911039T ES2136662T3 ES 2136662 T3 ES2136662 T3 ES 2136662T3 ES 93911039 T ES93911039 T ES 93911039T ES 93911039 T ES93911039 T ES 93911039T ES 2136662 T3 ES2136662 T3 ES 2136662T3
Authority
ES
Spain
Prior art keywords
presentation
pharmaceutical
forms
pectin
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93911039T
Other languages
English (en)
Inventor
Dilip J Gole
Paul K Wilkinson
J Desmond Davies
R Saul Levinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Janssen Pharmaceutica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Inc filed Critical Janssen Pharmaceutica Inc
Application granted granted Critical
Publication of ES2136662T3 publication Critical patent/ES2136662T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA FORMA DE DOSIFICACION SOLIDA, QUE SE DISUELVE RAPIDAMENTE, ESTA DEFINIDA POR UNA MATRIZ QUE CONTIENE GELATINA Y/O PROTEINA DE FIBRA DE SOYA, Y UNO O MAS AMINOACIDOS, CONTENIENDO DESDE 2 A 12 ATOMOS DE CARBONO DE PROMEDIO.
ES93911039T 1992-05-06 1993-05-03 Formas de presentacion farmaceuticas y de otro tipo. Expired - Lifetime ES2136662T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87975492A 1992-05-06 1992-05-06

Publications (1)

Publication Number Publication Date
ES2136662T3 true ES2136662T3 (es) 1999-12-01

Family

ID=25374827

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93911039T Expired - Lifetime ES2136662T3 (es) 1992-05-06 1993-05-03 Formas de presentacion farmaceuticas y de otro tipo.

Country Status (28)

Country Link
EP (1) EP0642334B1 (es)
JP (1) JPH07508019A (es)
KR (1) KR100194241B1 (es)
CN (1) CN1085081A (es)
AT (1) ATE183387T1 (es)
BG (1) BG62681B1 (es)
CA (1) CA2135062C (es)
CL (1) CL2004001180A1 (es)
CY (1) CY2175B1 (es)
CZ (1) CZ283882B6 (es)
DE (1) DE69326063T2 (es)
DK (1) DK0642334T3 (es)
ES (1) ES2136662T3 (es)
FI (1) FI111333B (es)
GR (1) GR3031180T3 (es)
HK (1) HK1010693A1 (es)
HU (2) HU227532B1 (es)
IL (1) IL105553A (es)
MY (1) MY112231A (es)
NO (1) NO308065B1 (es)
NZ (1) NZ252526A (es)
PL (1) PL172354B1 (es)
RO (1) RO112990B1 (es)
RU (1) RU2131244C1 (es)
SG (1) SG47430A1 (es)
SK (1) SK280129B6 (es)
TW (1) TW380053B (es)
WO (1) WO1993023017A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837276A (en) * 1994-09-02 1998-11-17 Delab Apparatus for the delivery of elongate solid drug compositions
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
GB9504201D0 (en) * 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
FR2740686B1 (fr) 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
PL188231B1 (pl) 1996-06-17 2004-12-31 Janssen Pharmaceutica Nv Sposób wytwarzania stałej, szybko rozpadającej się postaci dawkowania, stała, szybko rozpadająca się postać dawkowania oraz arkusz wykonany z folii ztworzywa sztucznego albo z metalu
KR100823524B1 (ko) * 1996-06-17 2008-11-12 얀센 파마슈티카 엔.브이. 양쪽볼록형급속붕괴제형
BR9709907A (pt) * 1996-06-17 1999-08-10 Janssen Pharmaceutica Nv Marcacão de formas de dosagem de rápida desintegracão
KR100782897B1 (ko) * 1996-06-17 2008-04-08 얀센 파마슈티카 엔.브이. 급속붕괴제형의표시방법
GB9621614D0 (en) * 1996-10-17 1996-12-11 Cultech Limited Vitamin delivery
GB9802088D0 (en) * 1998-01-30 1998-03-25 Scherer Ltd R P Pharmaceutical products
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
ATE198348T1 (de) 1998-11-11 2001-01-15 Dalli Werke Waesche & Koerperp Verdichtetes granulat, herstellungsverfahren und verwendung als sprengmittel für gepresste formkörper
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
FR2828380B1 (fr) * 2001-08-10 2005-07-29 Fontarome Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
AR038575A1 (es) 2002-02-22 2005-01-19 Pharmacia Corp Formulacion oftalmica con nueva composicion de goma
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
WO2004024188A1 (ja) * 2002-09-12 2004-03-25 Nihon Medi-Physics Co., Ltd. 薬物の血漿蛋白質結合を制御するための製剤
US20040052853A1 (en) * 2002-09-16 2004-03-18 Cp Kelco, U.S., Inc. Pectin films
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
CN1878563A (zh) 2003-11-10 2006-12-13 西摩·H·费恩 包含低剂量去氨加压素的药物组合物
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
US7939511B2 (en) 2004-09-28 2011-05-10 Senju Pharmaceutical Co., Ltd. Ophthalmic composition containing xanthan gum and amino acid
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005009241A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
EP2156842A4 (en) * 2007-06-01 2013-01-23 Kyowa Hakko Bio Co Ltd ORAL COMPOSITION
WO2009092601A1 (en) 2008-01-25 2009-07-30 Grünenthal GmbH Pharmaceutical dosage form
MX2010012039A (es) 2008-05-09 2010-11-30 Gruenenthal Gmbh Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
RU2567723C2 (ru) 2009-07-22 2015-11-10 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
PL2493457T3 (pl) * 2009-10-30 2018-01-31 Ix Biopharma Ltd Szybko rozpuszczalna stała postać dawkowana
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
PE20131126A1 (es) 2010-09-02 2013-10-21 Gruenenthal Chemie Forma de dosificacion resistente a alteracion que comprende un polimero anionico
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
WO2013156453A1 (en) 2012-04-18 2013-10-24 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AR096438A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
US9468606B2 (en) * 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
JP2017516789A (ja) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エタノール過量放出に対して防護されている多粒子
KR20170139158A (ko) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB698767A (en) 1950-07-06 1953-10-21 Bayer Ag Readily soluble dry preparations of swelling substances
US2758644A (en) * 1953-07-30 1956-08-14 Virlouvet Jacques Control system for slatted roller blinds
US3234091A (en) 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE2017373A1 (de) 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) 1977-07-20 1981-03-10 George K. E. Gregory Packages
JPS5913887B2 (ja) 1979-10-30 1984-04-02 株式会社ブリヂストン 溶融金属用濾過材
DE3404382A1 (de) 1984-02-08 1985-08-14 Anton Dr. 4400 Münster Härle Saugflasche zum absaugen von sekreten aus wundhoehlen
US4697630A (en) * 1987-03-17 1987-10-06 General Clutch Corporation Tilt mechanism for venetian blinds
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Also Published As

Publication number Publication date
NZ252526A (en) 1995-09-26
CA2135062C (en) 1999-05-25
MY112231A (en) 2001-05-31
HU227532B1 (en) 2011-07-28
IL105553A (en) 1998-01-04
RO112990B1 (ro) 1998-03-30
GR3031180T3 (en) 1999-12-31
BG62681B1 (bg) 2000-05-31
DE69326063D1 (de) 1999-09-23
DE69326063T2 (de) 2000-03-16
CN1085081A (zh) 1994-04-13
EP0642334B1 (en) 1999-08-18
FI111333B (fi) 2003-07-15
KR100194241B1 (ko) 1999-06-15
WO1993023017A1 (en) 1993-11-25
FI945198A0 (fi) 1994-11-04
CZ265494A3 (en) 1995-02-15
AU4232293A (en) 1993-12-13
TW380053B (en) 2000-01-21
IL105553A0 (en) 1993-08-18
CZ283882B6 (cs) 1998-06-17
HUT68224A (en) 1995-06-28
DK0642334T3 (da) 2000-04-17
NO944207D0 (no) 1994-11-04
SK132094A3 (en) 1995-07-11
CL2004001180A1 (es) 2005-06-03
AU677198B2 (en) 1997-04-17
SK280129B6 (sk) 1999-08-06
NO944207L (no) 1994-11-04
EP0642334A1 (en) 1995-03-15
HU211549A9 (en) 1995-12-28
ATE183387T1 (de) 1999-09-15
RU2131244C1 (ru) 1999-06-10
BG99158A (bg) 1995-05-31
CA2135062A1 (en) 1993-11-25
RU94046029A (ru) 1996-11-10
PL172354B1 (pl) 1997-09-30
FI945198A (fi) 1994-11-04
KR950700728A (ko) 1995-02-20
NO308065B1 (no) 2000-07-17
CY2175B1 (en) 2002-08-23
JPH07508019A (ja) 1995-09-07
SG47430A1 (en) 1998-04-17
HK1010693A1 (en) 1999-06-25

Similar Documents

Publication Publication Date Title
ES2136662T3 (es) Formas de presentacion farmaceuticas y de otro tipo.
DE69426984T2 (de) Arzneizubereitung
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
IT1244548B (it) Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
ES2028796T3 (es) Procedimiento para producir preparados farmaceuticos que contienen interferon alfa.
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
ES2107284T3 (es) Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DK0621775T3 (da) Peptidlægemiddelholdige pellets, deres fremstilling og anvendelse.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
ES2063796T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina.
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
MX9102088A (es) Complejos que contienen acidos s(+) fenilalcanos y alfa-aminoacidos
ES2089091T3 (es) Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos.
DE3866747D1 (de) Jod enthaltende pharmazeutische zubereitung.
ES2063332T3 (es) Solucion de infusion nefroprotectora.
IT1241459B (it) Composizioni farmaceutiche per la somministrazione rettale di calcitonina
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
KR900003198A (ko) 신규 글루탐산 유도체, 그의 염, 그의 제조방법, 이들의 의약품으로서의 용도 및 이들을 함유한 조성물
KR910007524A (ko) 관상동맥 부전증 치료를 위한 약제 제조에 있어 카보티오아미드 1-옥사이드의 이용
FI910788A (fi) Syntes av lh-rh-analoger medelst temporaer minimal skydd.
KR910009280A (ko) 원발성 흉막암 치료용 제약 조성물의 제조에 있어서 감마 인터페론 활성을 갖는 폴리펩티드의 용도

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 642334

Country of ref document: ES